Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB0800217	MK-0524A	Laropiprant;Niacin SR	Active ingredient	Chemical Drugs	Supplementary Application	2008-04-11	Merck & Co., Inc.	Merck & Co Inc	Certificate Issued	2008-08-12	view
JXHL0600205	MK-0524A	Laropiprant;Niacin SR	Active ingredient	Chemical Drugs(1.5)	Import Drug Application	2006-08-04		Merck & Co Inc	Certificate Issued	2007-02-27	view
JXHL0600206	MK-0524A	Laropiprant;Niacin SR	Active ingredient	Chemical Drugs(1.5)	Import Drug Application	2006-08-04		Merck & Co Inc	Certificate Issued	2007-02-26	view